about
New insights into the pathogenesis and therapeutics of episodic ataxia type 1Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels.Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentationsPearls & Oy-sters: Episodic ataxia type 2: Case report and review of the literature.Acetazolamide potentiates the afferent drive to prefrontal cortex in vivo.Ataxia in children: early recognition and clinical evaluation.
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Acetazolamide-responsive ataxia.
@en
type
label
Acetazolamide-responsive ataxia.
@en
prefLabel
Acetazolamide-responsive ataxia.
@en
P356
P1476
Acetazolamide-responsive ataxia.
@en
P2093
Vikas Kotagal
P304
P356
10.1055/S-0033-1334475
P577
2012-11-01T00:00:00Z